Other researchers found that increased levels of ROS, whose production is enhanced in endothelial dysfunction, upregulates iNOS and eNOS expression in human coronary artery endothelial cells (HCAECs) both in vitro and in vivo. The gene discussed is NOS2; the disease is endothelial dysfunction.